Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 836,696 |
|
|||||
| News | - | ||||||
| Day High | 45.58 | Low High |
|||||
| Day Low | 43.13 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc | RARE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 1.42 | 3.25% | 45.11 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 43.74 | 43.13 | 45.58 | 45.11 | 43.69 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 13,100 | 836,696 | $ 45.11 | $ 37,743,740 | - | 31.52 - 54.98 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:19:25 | 2 | $ 45.13 | USD |
Ultragenyx Pharmaceutical (RARE) Options Flow Summary
Ultragenyx Pharmaceutical Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.71B | 82.34M | - | 434.25M | -606.64M | -7.37 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ultragenyx Pharmaceutical News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RARE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 42.85 | 45.58 | 41.07 | 43.18 | 763,537 | 2.26 | 5.27% |
| 1 Month | 45.97 | 52.56 | 41.07 | 46.16 | 711,500 | -0.86 | -1.87% |
| 3 Months | 46.21 | 54.56 | 41.07 | 47.44 | 701,184 | -1.10 | -2.38% |
| 6 Months | 32.74 | 54.56 | 31.52 | 44.03 | 786,408 | 12.37 | 37.78% |
| 1 Year | 42.12 | 54.98 | 31.52 | 42.73 | 753,923 | 2.99 | 7.10% |
| 3 Years | 110.10 | 119.54 | 31.52 | 54.55 | 633,822 | -64.99 | -59.03% |
| 5 Years | 64.75 | 179.647 | 31.52 | 61.88 | 571,799 | -19.64 | -30.33% |
Ultragenyx Pharmaceutical Description
| Ultragenyx Pharmaceutical Inc is a US-based biopharmaceutical company. It identifies, acquires, develops, and commercialize novel products for the treatment of serious rare and ultra-rare diseases, with the focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. |
